Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 4 of about 4   

Articles published

NVS 94.74 +0.06 (0.06%)
price chart
New pharmacovigilance system debuts in EU
New rules governing the monitoring, identification and assessment of adverse events caused by pharmaceuticals are introduced, with the aim of making the EU-wide system for overseeing drug safety and 'benefit-risk' more transparent and robust.
Dr. Reddys Launches Generic Lipitor
Other launches include Dr. Reddy's generic version of Novartis AG's (NVS - Analyst Report) over-the-counter (OTC) drug, Prevacid and Bristol-Myers Squibb & Co.
Another Copaxone Win for Teva
Teva had filed a patent infringement lawsuit against Momenta Pharmaceuticals, Inc. (MNTA - Analyst Report)/Sandoz Inc. and Mylan/Natco Pharmaceuticals, which were looking to launch their generic versions of Copaxone. Copaxone is approved for the ...
Roche Building On Its Strengths
... in Europe. Overall profitability was okay. Core operating profit rose about 5%, with solid 7% growth in pharmaceuticals and a 6% decline in diagnostics due to bad debt expense in emerging markets and an elevated level of system placements (which ...